Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | |||||||||
| Earning before tax | ---- | -11.58%269.77M | ---- | 24.96%305.11M | 1.37%133.98M | -17.48%244.16M | --132.17M | 25.84%295.87M | --235.12M |
| Profit adjustment | |||||||||
| Interest (income) - adjustment | ---- | 32.27%-3.72M | ---- | 32.68%-5.49M | 33.92%-3.12M | -36.65%-8.16M | ---4.72M | -36.30%-5.97M | ---4.38M |
| Impairment and provisions: | ---- | 1,804.37%20.49M | ---- | 110.67%1.08M | 110.68%531K | -176.43%-10.09M | ---4.97M | 238.36%13.2M | ---9.54M |
| -Impairment of property, plant and equipment (reversal) | ---- | --15.21M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | 391.08%5.28M | ---- | 110.67%1.08M | 110.68%531K | -176.43%-10.09M | ---4.97M | 238.36%13.2M | ---9.54M |
| Revaluation surplus: | ---- | 93.75%-5K | ---- | 42.86%-80K | -35.00%-54K | 82.57%-140K | ---40K | 75.73%-803K | ---3.31M |
| -Other fair value changes | ---- | 93.75%-5K | ---- | 42.86%-80K | -35.00%-54K | 82.57%-140K | ---40K | 75.73%-803K | ---3.31M |
| Asset sale loss (gain): | ---- | -469.09%-203K | ---- | 103.54%55K | -322.45%-218K | -2,581.03%-1.56M | --98K | 95.54%-58K | ---1.3M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.51M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -469.09%-203K | ---- | 103.54%55K | -322.45%-218K | -2,581.03%-1.56M | --98K | -128.29%-58K | --205K |
| Depreciation and amortization: | ---- | 15.38%61.16M | ---- | 17.93%53.01M | 4.92%24.08M | 1.51%44.95M | --22.95M | -9.04%44.28M | --48.68M |
| -Amortization of intangible assets | ---- | 13.71%1.92M | ---- | 11.76%1.69M | 12.33%829K | -12.59%1.51M | --738K | 19.86%1.73M | --1.45M |
| Financial expense | ---- | 13.18%71.46M | ---- | 11.02%63.13M | -9.74%31.14M | -11.37%56.87M | --34.5M | -11.65%64.16M | --72.62M |
| Exchange Loss (gain) | ---- | -4,864.29%-1.33M | ---- | -83.91%28K | 433.33%30K | 1,550.00%174K | ---9K | 97.07%-12K | ---409K |
| Special items | ---- | -306.28%-40.44M | ---- | 121.63%19.6M | -54.29%-5.7M | 184.50%8.85M | ---3.69M | 113.02%3.11M | ---23.87M |
| Operating profit before the change of operating capital | ---- | -13.58%377.18M | ---- | 30.26%436.44M | 2.49%180.67M | -19.02%335.06M | --176.29M | 31.94%413.78M | --313.61M |
| Change of operating capital | |||||||||
| Inventory (increase) decrease | ---- | -22.27%-479.4M | ---- | -251.79%-392.08M | -252.04%-428.5M | 183.15%258.3M | --281.84M | -10.25%-310.62M | ---281.73M |
| Accounts receivable (increase)decrease | ---- | -496.56%-130.87M | ---- | -15.15%-21.94M | 129.98%9.45M | 13.23%-19.05M | ---31.52M | -129.93%-21.96M | --73.36M |
| Accounts payable increase (decrease) | ---- | -119.85%-96.84M | ---- | 4,992.21%487.8M | 6,791.42%273.8M | -140.81%-9.97M | --3.97M | 324.48%24.44M | ---10.89M |
| prepayments (increase)decrease | ---- | 62.15%-34.69M | ---- | -632.28%-91.65M | 57.79%-92.17M | 67.97%17.22M | ---218.35M | 119.33%10.25M | ---53.02M |
| Special items for working capital changes | ---- | 167.12%54.22M | ---- | -762.94%-80.79M | 175.17%9.53M | -70.75%-9.36M | ---12.68M | 94.87%-5.48M | ---106.84M |
| Cash from business operations | ---- | -191.89%-310.4M | ---- | -40.97%337.79M | -123.66%-47.22M | 418.29%572.19M | --199.55M | 268.53%110.4M | ---65.51M |
| Other taxs | ---- | 69.55%-28.12M | ---- | -183.51%-92.33M | -179.39%-9.36M | 66.73%-32.57M | --11.79M | -84.31%-97.9M | ---53.12M |
| Interest received - operating | ---- | -10.94%1.33M | ---- | -5.52%1.49M | -9.93%689K | 4.02%1.58M | --765K | 270.66%1.52M | --409K |
| Interest paid - operating | ---- | 5.03%-16.4M | ---- | 6.77%-17.27M | 23.33%-7.13M | 7.13%-18.53M | ---9.3M | 40.40%-19.95M | ---33.47M |
| Special items of business | 579.40%65.61M | ---- | ---13.69M | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from operations | 579.40%65.61M | -253.95%-353.59M | 78.29%-13.69M | -56.06%229.68M | -131.08%-63.03M | 8,906.57%522.67M | --202.8M | 96.09%-5.94M | ---151.69M |
| Cash flow from investment activities | |||||||||
| Interest received - investment | 12.42%1.71M | -47.13%2.45M | -51.96%1.52M | -17.51%4.63M | -4.64%3.17M | 56.48%5.61M | --3.32M | 172.15%3.59M | --1.32M |
| Decrease in deposits (increase) | 21.05%115M | 153.19%50M | 147.50%95M | -146.88%-94M | -471.43%-200M | 2,123.33%200.5M | ---35M | 103.86%9.02M | ---233.73M |
| Sale of fixed assets | ---- | -95.68%13K | -99.32%2K | 2,050.00%301K | 4,100.00%294K | -90.85%14K | --7K | --153K | ---- |
| Purchase of fixed assets | 65.85%-8.47M | -55.58%-155.04M | 65.27%-24.81M | -35.18%-99.65M | -244.56%-71.45M | -6.11%-73.72M | ---20.74M | -5.10%-69.47M | ---66.1M |
| Purchase of intangible assets | 65.37%-2.32M | -567.29%-9.96M | -638.90%-6.69M | 18.02%-1.49M | -3.78%-905K | -92.59%-1.82M | ---872K | 37.42%-945K | ---1.51M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --864K |
| Recovery of cash from investments | ---- | -80.04%6.01M | -62.59%6.01M | -73.43%30.08M | -79.08%16.05M | -89.46%113.22M | --76.76M | -71.11%1.07B | --3.72B |
| Cash on investment | -66.67%-10M | 79.74%-6.08M | 62.50%-6M | 71.98%-30M | 77.91%-16M | 89.30%-107.07M | ---72.42M | 73.32%-1B | ---3.75B |
| Net cash from investment operations | 47.51%95.92M | 40.78%-112.6M | 124.19%65.03M | -239.05%-190.13M | -449.34%-268.84M | 766.60%136.74M | ---48.94M | 104.74%15.78M | ---332.56M |
| Net cash before financing | 214.61%161.53M | -1,278.93%-466.2M | 115.47%51.34M | -94.00%39.54M | -315.68%-331.86M | 6,598.61%659.41M | --153.87M | 102.03%9.84M | ---484.25M |
| Cash flow from financing activities | |||||||||
| New borrowing | -11.45%800.74M | 47.29%2.1B | -16.57%904.3M | 25.42%1.42B | 47.27%1.08B | -25.53%1.14B | --736M | 6.13%1.53B | --1.44B |
| Refund | -2.00%-636.2M | -5.12%-1.54B | 20.35%-623.72M | 10.76%-1.47B | -4.55%-783.05M | -18.60%-1.64B | ---749M | -47.26%-1.38B | ---940.48M |
| Issuing shares | ---- | --487.16M | ---- | ---- | ---- | --50M | ---- | ---- | ---- |
| Interest paid - financing | -27.09%-33.08M | -18.10%-52.41M | -12.23%-26.03M | -13.40%-44.38M | 4.75%-23.19M | 10.00%-39.14M | ---24.35M | -11.33%-43.49M | ---39.06M |
| Dividends paid - financing | ---- | ---91.63M | ---91.63M | ---- | ---- | -7,036.45%-78.72M | ---78.72M | 95.20%-1.1M | ---22.98M |
| Issuance expenses and redemption of securities expenses | ---- | -79.96%-27.71M | ---2.14M | ---15.4M | ---- | ---- | ---- | ---- | ---- |
| Other items of the financing business | ---- | ---- | ---- | ---- | ---- | ---2.62M | ---2.62M | ---- | ---6.77M |
| Net cash from financing operations | -18.40%127.9M | 894.13%865.05M | -42.71%156.73M | 81.46%-108.93M | 319.50%273.57M | -779.13%-587.62M | ---124.63M | -79.35%86.53M | --418.95M |
| Effect of rate | 3,885.87%3.67M | 1,463.21%1.45M | 295.74%92K | -312.00%-106K | -4,600.00%-47K | 1,766.67%50K | ---1K | -400.00%-3K | --1K |
| Net Cash | 39.09%289.42M | 674.83%398.86M | 456.94%208.08M | -196.65%-69.39M | -299.40%-58.3M | -25.50%71.79M | --29.24M | 247.57%96.37M | ---65.3M |
| Begining period cash | 256.82%556.17M | -30.84%155.87M | -30.84%155.87M | 46.80%225.36M | 46.80%225.36M | 168.62%153.52M | --153.52M | -53.33%57.15M | --122.45M |
| Cash at the end | 133.29%849.26M | 256.82%556.17M | 117.96%364.03M | -30.84%155.87M | -8.61%167.02M | 46.80%225.36M | --182.75M | 168.62%153.52M | --57.15M |
| Cash balance analysis | |||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
| Auditor | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Touche Tohmatsu CPA LLP | Deloitte Touche Tohmatsu CPA LLP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.